NURS FPX 4905 Assessment 4 Intervention Proposal

Student Name Capella University NURS-FPX4905 Capstone Project for Nursing Prof. Name Date Intervention Proposal The Longevity Center is a niche clinical organization specializing in preventive and regenerative medicine services, including hormone optimization, advanced biomarker testing, and cellular-based therapies. Its clientele primarily consists of individuals pursuing proactive and personalized health management strategies. Despite its innovative clinical model, operational inefficiencies have contributed to delays in diagnostic clarification, particularly among patients presenting with multifactorial or ambiguous symptomatology. In regenerative medicine, delayed identification of hormonal dysregulation, inflammatory markers, autoimmune triggers, or micronutrient deficiencies can significantly compromise therapeutic outcomes (Sierra et al., 2021). This intervention proposal introduces a structured systems-level improvement plan centered on workflow redesign and the integration of a Clinical Decision Support System (CDSS). The objective is to enhance diagnostic timeliness, improve clinical precision, and support evidence-informed regenerative practice. Identification of the Practice Issue What is the primary clinical problem affecting patient outcomes at The Longevity Center? The predominant issue is prolonged diagnostic turnaround time for patients with complex or nonspecific symptoms. Such delays postpone initiation of therapies including peptide protocols, bioidentical hormone replacement, platelet-rich plasma (PRP), and stem-cell–based interventions. Because regenerative therapies depend heavily on early and accurate biomarker interpretation, inefficiencies in diagnosis undermine treatment efficacy and patient satisfaction (Sierra et al., 2021). Which operational factors contribute to diagnostic delays? A structured internal review identified several workflow deficiencies: These gaps introduce clinical variability and increase the risk of missed or late identification of clinically significant abnormalities. In precision medicine environments, such variability directly impacts care quality and therapeutic optimization. Current Practice How are intake and diagnostic workflows currently structured? At present, patient onboarding relies on paper-based intake documentation that is subsequently transcribed into the Electronic Health Record (EHR). This redundant data entry process increases transcription error risk and prolongs administrative processing time. Laboratory data are manually reviewed by providers without automated notification systems for critical or abnormal results. No computerized decision support tools are embedded within the EHR to assist with differential diagnosis formulation or regenerative protocol selection. Table 1 summarizes key operational gaps. Table 1Current Workflow Limitations Clinical Domain Existing Process Impact on Regenerative Care Patient Intake Paper forms manually entered into EHR Increased documentation errors; slowed throughput Laboratory Review Manual interpretation without alerts Delayed recognition of abnormal biomarkers Clinical Decision Support No CDSS integration Inconsistent application of evidence-based protocols Staff Workflow Non-standardized processes Variability in care timelines and treatment readiness The absence of standardized diagnostic algorithms increases variability in therapies such as hormone modulation, PRP procedures, and cellular rejuvenation protocols. Proposed Strategy What intervention is recommended to mitigate diagnostic inefficiencies? The proposed initiative involves implementing a standardized digital intake system integrated directly into the EHR, coupled with deployment of a CDSS. The intervention focuses on three domains: intake optimization, automated laboratory surveillance, and evidence-guided clinical reasoning. This systems-based approach aligns technological infrastructure with regenerative medicine workflows (Wolfien et al., 2023). What are the essential components of the intervention? The strategy includes the following structured elements: The CDSS will provide differential diagnosis suggestions, flag abnormal biomarker trends, and align treatment recommendations with established regenerative medicine evidence. Impact on Quality, Safety, and Cost How will this intervention improve quality of care? Standardized intake processes combined with automated decision support reduce diagnostic variability and strengthen adherence to evidence-based regenerative protocols. Enhanced biomarker tracking improves diagnostic precision and supports appropriate stem-cell–based or hormone-based interventions (Ghasroldasht et al., 2022). How does the strategy enhance patient safety? Automated alerts reduce the probability of overlooked critical laboratory values. Improved communication between disciplines decreases handoff errors and promotes safer initiation of biologic or cellular therapies (White et al., 2023). What financial implications are anticipated? Early identification of underlying imbalances can prevent costly emergency complications and redundant diagnostic testing. Although initial technology investment is required, cost savings are expected through improved efficiency and avoidance of high-cost acute care episodes. NURS FPX 4905 Assessment 4 Intervention Proposal Table 2Projected Outcomes of CDSS Integration Domain Expected Improvement Regenerative Care Example Quality Greater diagnostic accuracy; reduced omissions Early identification of micronutrient insufficiencies Safety Automated abnormal lab alerts Prevention of untreated hormonal dysregulation Cost Reduced redundant testing and emergency visits Avoidance of $8,000–$15,000 acute care episodes Role of Technology In what ways does technology enable sustainable improvement? Technology functions as the central enabling mechanism of this intervention. CDSS integration within the EHR provides real-time, evidence-informed clinical guidance, including abnormal lab flagging, differential diagnosis assistance, and protocol recommendations (Derksen et al., 2025). Such systems decrease cognitive burden on clinicians and improve detection of longitudinal biomarker trends. Shared dashboards facilitate interdisciplinary transparency, while data analytics enable continuous quality improvement cycles. Ethical oversight remains essential to ensure appropriate data governance and responsible application of regenerative technologies (Hermerén, 2021). Implementation at Practicum Site What is the implementation framework? The rollout will follow a staged implementation model beginning with a pilot cohort of clinicians. Workflow mapping, simulation testing, and iterative refinement will precede organization-wide expansion (Klein, 2025). What barriers are anticipated and how will they be mitigated? Anticipated Barrier Mitigation Strategy Staff resistance Structured training and change management initiatives Budget limitations Phased licensing and exploration of academic partnerships Technical integration challenges Pre-implementation system testing and IT collaboration (Makhni & Hennekes, 2023) This phased strategy minimizes disruption while supporting sustainable adoption. Interprofessional Collaboration Which professional roles are integral to successful execution? Effective integration of CDSS technology requires coordinated interprofessional participation. Table 3Interprofessional Contributions Role Primary Responsibility Application in Regenerative Care Nurses & Nurse Practitioners Conduct comprehensive digital intake assessments Identify contraindications for PRP or peptide therapy Physicians Define diagnostic thresholds and treatment algorithms Determine candidacy for cellular-based interventions IT Specialists Configure and maintain EHR-CDSS interoperability Establish regenerative-specific biomarker alerts Administrative Personnel Coordinate training and compliance tracking Organize interdisciplinary review sessions Collaborative governance ensures that both technological systems and clinical pathways function cohesively. Conclusion The integration of standardized digital intake protocols with a Clinical Decision Support System represents a strategic advancement for The Longevity Center. By reducing diagnostic delays, improving workflow reliability, and embedding evidence-based regenerative guidance into clinical